October 4, 2011

Growing numbers of Americans with asthma and chronic obstructive pulmonary disease are driving innovation among drug makers, according to a new report by Frost & Sullivan.

October 4, 2011

Taro Pharmaceutical Industries recently appointed a new member to its board, following the resignation of Hasmukh Shah.

October 4, 2011

The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO's drugs by the end of the decade.

October 3, 2011

Pharmacy benefit manager Express Scripts has launched a suite of services for drug makers through HealthBridge Pharma & Biotech to provide a single-solution approach to patient care.

October 3, 2011

The Food and Drug Administration has approved a generic antibiotic made by Sagent Pharmaceuticals, Sagent said.

September 30, 2011

Drug maker Takeda has completed its acquisition of another drug maker.

September 29, 2011

The Food and Drug Administration has declined to approve a vaccine developed by GlaxoSmithKline, the drug maker said.

September 29, 2011

McNeil-PPC announced Wednesday that the acquisition of full ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals joint venture has been completed.

September 29, 2011

Last year, U.S. Customs and Border Protection seized $5.6 million worth of illegal pharmaceutical products, a 170% increase over 2005. Meanwhile, global sales of counterfeit medicines were estimated to be more than $75 billion last year, 90% more than in 2005. In response, Pfizer and the National Association of Boards of Pharmacy announced Thursday the launch of an effort to educate patients on how to safely buy medicines online and about the risks of counterfeit drugs.

September 28, 2011

Supermarket pharmacies could see a slight rise in gross profits next year as branded drugs lose patent protection and go generic, according to a new report by Moody's Investors Service.

September 27, 2011

AmerisourceBergen on Tuesday purchased TheraCom, a subsidiary of CVS Caremark that provides a wide range of support to pharmaceutical and biotechnology drug manufacturers, including consulting and reimbursement services, for $250 million.

September 27, 2011

A growing number of Americans are putting their health at risk in order to save money, according to a new study.

September 22, 2011

Dr. Reddy's Labs has launched a drug for treating Alzheimer's disease, the company said.

September 22, 2011

A report commissioned by the Generic Pharmaceutical Association has drawn applause from manufacturers and a retail pharmacy industry group.

September 22, 2011

Drug maker Orexigen Therapeutics said it had identified a "clear and feasible path" for the approval of its drug for treating obesity by working with the Food and Drug Administration.

September 21, 2011

Generic drug maker Mylan has entered an agreement with Hoffmann La Roche concerning its version of an oral chemotherapy drug.

September 21, 2011

Generic drugs have saved U.S. consumers and the healthcare system $931 billion over the last 10 years, according to a report released Wednesday by the Generic Pharmaceutical Association.

September 20, 2011

Only one stakeholder stands to gain from the proposed merger of Express Scripts and Medco — and that would be the new “mega PBM” the deal would create, not payers, and definitely not patients, either.

September 19, 2011

The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

September 16, 2011

A drug made by Boehringer Ingelheim and Eli Lilly showed "meaningful and durable" reductions in blood sugar in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented Friday at a conference in Europe.

September 16, 2011

Pharmacy benefit manager Express Scripts will provide services for patients using a drug to manage a debilitating side effect of many anti-cancer treatments, ESI said.

September 15, 2011

GlaxoSmithKline and Amicus Therapeutics have started a late-stage clinical trial for a drug to treat a rare genetic disorder, the companies said.

September 15, 2011

The Food and Drug Administration has approved a generic drug for epilepsy made by Lupin Pharmaceuticals, the drug maker said.

September 14, 2011

The National Community Pharmacists Association on Wednesday expressed its concerns over track-and-trace systems in its comments submitted to the U.S. Senate Health, Education, Labor and Pensions Committee hearing, “Securing the Pharmaceutical Supply Chain.”